journal article·2023-10-11

Construction of Phlorotannin-Based Nanoparticles for Alleviating Acute Liver Injury

Fengxian Luo, Beiwei Zhu, Di Wu, Yu Xu, Tao Chen, Yanfei Li, Jiangning Hu

ACS Applied Materials & Interfaces· Volume 15· Issue 40
Publisher page

Abstract

Acute liver injury (ALI) is a severe health condition with limited treatment options. Phlorotannin (PT), a natural compound extracted from seaweeds, has shown potential in improving liver function. However, its poor stability and bioavailability have limited its applications in vivo. In this study, we developed PT-based nanoparticles (NPs) through a Mannich reaction with glycine, which exhibited good biocompatibility and prolonged circulation time in vivo. Our results revealed that the PT NPs possess strong free radical scavenging ability, effectively reducing reactive oxygen species (ROS) and alleviating oxidative stress and proinflammatory responses in the H 2 O 2 -induced oxidative damage model of HepG2 cells. Furthermore, the PT NPs effectively attenuated oxidative stress and inflammation in the liver tissue of carbon tetrachloride (CCl 4 )-induced liver injury mice by regulating the Nrf2/HO-1 signaling pathway. In summary, our results suggested that the PT NPs could serve as a promising nano-therapeutic strategy for alleviating ALI.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Curcumin's Biomedical Applications · Liver physiology and pathology · Selenium in Biological Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, China

Collaborative Innovation Center of Seafood Deep Processing, Dalian Polytechnic University, Dalian 116034, China

Funding

National Natural Science Foundation of China · Key Laboratory of Research and Development of Natural Bioactive Components of Ethnic Medicines of Dalian City · Liaoning Bai Qian Wan Talents Program · Central Funds Guiding the Local Science and Technology Development

References (50)

Show source-provided references
1. 10.1038/s41418-019-0412-810.1038/s41418-019-0412-8 ↗
2. 10.1002/advs.20210398210.1002/advs.202103982 ↗
3. 10.1039/D2TB01505F10.1039/D2TB01505F ↗
4. 10.1111/1541-4337.1233510.1111/1541-4337.12335 ↗
5. 10.3390/ijerph1902063810.3390/ijerph19020638 ↗
6. 10.5009/gnl1647710.5009/gnl16477 ↗
7. 10.1155/2016/743279710.1155/2016/7432797 ↗
8. 10.1039/C7FO00355B10.1039/C7FO00355B ↗
9. 10.1021/acs.jafc.5b0175010.1021/acs.jafc.5b01750 ↗
10. 10.3390/nu1301027310.3390/nu13010273 ↗
11. 10.3390/nu1109214710.3390/nu11092147 ↗
12. 10.2147/IJN.S21032010.2147/IJN.S210320 ↗
13. 10.1021/acs.accounts.0c0015010.1021/acs.accounts.0c00150 ↗
14. 10.1016/j.tifs.2021.08.00910.1016/j.tifs.2021.08.009 ↗
15. 10.1021/acs.jafc.6b0206810.1021/acs.jafc.6b02068 ↗
16. 10.1021/acssuschemeng.8b0161310.1021/acssuschemeng.8b01613 ↗
17. 10.1021/acsami.0c1028210.1021/acsami.0c10282 ↗
18. 10.4155/bio-2018-024610.4155/bio-2018-0246 ↗
19. 10.1002/anie.20181008710.1002/anie.201810087 ↗
20. 10.1016/j.procbio.2011.09.01510.1016/j.procbio.2011.09.015 ↗
21. 10.3390/molecules2201005610.3390/molecules22010056 ↗
22. 10.3390/md2012074210.3390/md20120742 ↗
23. 10.1016/j.etap.2011.09.00410.1016/j.etap.2011.09.004 ↗
24. 10.3390/md2006038410.3390/md20060384 ↗
25. 10.1016/j.foodres.2020.10958910.1016/j.foodres.2020.109589 ↗
26. 10.3390/md2004024310.3390/md20040243 ↗
27. 10.1016/j.algal.2021.10248410.1016/j.algal.2021.102484 ↗
28. 10.1016/j.cej.2021.13219710.1016/j.cej.2021.132197 ↗
29. 10.1021/acs.jafc.0c0369810.1021/acs.jafc.0c03698 ↗
30. 10.1038/srep2551810.1038/srep25518 ↗
31. 10.1021/acs.nanolett.2c0034910.1021/acs.nanolett.2c00349 ↗
32. 10.1002/adfm.20200918910.1002/adfm.202009189 ↗
33. 10.1021/acs.biomac.1c0136010.1021/acs.biomac.1c01360 ↗
34. 10.3390/ijms2005125010.3390/ijms20051250 ↗
35. 10.1021/acs.jafc.9b0707710.1021/acs.jafc.9b07077 ↗
36. 10.3389/fphar.2017.0019010.3389/fphar.2017.00190 ↗
37. 10.1039/C8FO02146E10.1039/C8FO02146E ↗
38. 10.1039/D1FO04222J10.1039/D1FO04222J ↗
39. 10.1016/j.neuint.2012.09.01110.1016/j.neuint.2012.09.011 ↗
40. 10.1002/adhm.20180071110.1002/adhm.201800711 ↗
41. 10.1016/j.biopha.2017.09.00310.1016/j.biopha.2017.09.003 ↗
42. 10.1039/c3fo30317a10.1039/c3fo30317a ↗
43. 10.3390/antiox1006097610.3390/antiox10060976 ↗
44. 10.1002/biof.152110.1002/biof.1521 ↗
45. Cai Z. · Int. J. Clin. Exp. Pathol. · 2015 · 8 · 8655
46. 10.1038/s41573-018-0008-x10.1038/s41573-018-0008-x ↗
47. 10.3748/wjg.v20.i36.1307910.3748/wjg.v20.i36.13079 ↗
48. 10.1097/WNR.000000000000096910.1097/WNR.0000000000000969 ↗
49. 10.1002/ptr.320710.1002/ptr.3207 ↗
50. 10.1002/ptr.617110.1002/ptr.6171 ↗